(C) Reuters. Vials of Pfizer’s coronavirus disease (COVID-19) vaccine are seen at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York
GENEVA (Reuters) – The head of the GAVI vaccine alliance said on Tuesday that there have been delays to some Pfizer (NYSE:PFE) BioNTech COVID-19 shot deliveries via the COVAX vaccine-sharing programme because of additional requirements set by the manufacturer.
Seth Berkley, CEO of the GAVI alliance that co-leads the COVAX multilateral vaccine facility with the World Health Organization (WHO), told journalists the requirements were partly related to indemnification issues.
At the same briefing, WHO adviser Bruce Aylward said it was still possible for COVID-19 vaccine rollouts to all participating countries to begin in the first 100 days of 2021 assuming that manufacturers can keep up with orders.
Pfizer requirements causing delays in COVAX deliveries: GAVI
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.